Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »

For full access to this article login to GEN Select now.

February 01, 2014 (Vol. 34, No. 3)

miRNA Therapeutics Heading to the Clinic

Despite Great Challenges, a Number of Companies Are Committed to Development Programs

  • Currently, there are two segments of the microRNA research marketplace that are translating toward the clinic: miR signatures as biomarkers with utility in diagnostics development and modulating miRs therapeutically as a means to modulate disease. The former segment is perhaps the most visible as there are a large ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.